Bleeding News and Research

RSS

FDA approves new drug to treat thrombocytopenia in adults with chronic liver disease

The U.S. Food and Drug Administration today approved Doptelet (avatrombopag) tablets to treat low blood platelet count (thrombocytopenia) in adults with chronic liver disease who are scheduled to undergo a medical or dental procedure. This is the first drug approved by the FDA for this use.

22 May 2018

Prestroke and poststroke oral anticoagulation therapy in AF patients

Oral anticoagulation therapy after stroke in patients with atrial fibrillation was associated with lower risk for recurrent blood vessel-blocking blood clots.

18 May 2018

UK military to use Celox Rapid hemostatic gauzes for treating gunshot and stab wounds

Celox Medical has won a new contract with Team Leidos to supply the UK Ministry of Defence with Celox Rapid haemostatic gauzes for use with all branches of the UK military to treat gunshot and stab wounds.

18 May 2018

Clot busting drug combo reduces risk of major strokes in high risk patients

In patients who have had a minor stroke or a transient ischemic stroke (TIA), the risk of getting a full-blown stroke or a major stroke is high. A new study has found that these high-risk individuals, when prescribed with clot-preventing drugs clopidogrel along with aspirin show a lower risk of getting major stroke.

18 May 2018

U.S. military personnel at greater risk for skin cancer than general population

When one considers the risks of military service, skin cancer may not be top of mind. According to research published in the Journal of the American Academy of Dermatology, however, U.S. military personnel are more likely to develop skin cancer than the general population.

17 May 2018

Drug combination may prevent secondary stroke in certain patients, study shows

Results from an international clinical trial of more than 4880 participants, published in the New England Journal of Medicine, show that combining clopidogrel and aspirin following a small stroke or experiencing minor stroke symptoms decreases risk of a new stroke, heart attack or other ischemic event within 90 days.

17 May 2018

New AI software accurately identifies commonest cause of stroke and dementia

Machine learning has detected one of the commonest causes of dementia and stroke, in the most widely used form of brain scan, more accurately than current methods.

17 May 2018

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

The research was part of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke trial -- a randomized, double-blind, placebo-controlled trial conducted between May 2010 and December 2017.

16 May 2018

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial has revealed.

16 May 2018

California hospital giant Sutter Health faces heavy backlash on prices

Cooking dinner one night in March, Mark Frizzell sliced his pinkie finger while peeling a butternut squash and couldn't stop the bleeding.

16 May 2018

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

The most severe allergic reaction, anaphylaxis, is the result of an inappropriate immune reaction following the introduction of a usually harmless antigen into the body.

16 May 2018

Study: Antibodies against hemorrhagic fever disarm two viruses of same family

Hemorrhagic fever viruses, so named for their ability to induce massive, and at times fatal, internal bleeding, captured the world's attention during the Ebola outbreak of 2014-2016 in West Africa.

15 May 2018

LogicBio team to present data on preclinical effectiveness of GeneRide platform

LogicBio Therapeutics, Inc., a genetic medicine company founded to develop safe medicines with lasting therapeutic benefit for children with life-threatening diseases, today announced it will be presenting data on the company's technology and robust preclinical pipeline at the annual meeting of the American Society of Gene & Cell Therapy at the Hilton Chicago, from May 16-19, 2018.

14 May 2018

Oral drug reduces venous thromboembolism recurrence among cancer patients

Research from the University of Warwick indicates that taking a tablet a day can help treat cancer patients of a potentially deadly condition.

11 May 2018

Brain magnetic stimulation can increase walking speed for stroke victims

A technique of magnetic stimulation of the brain can increase walking speed in patients who are undergoing rehabilitation after a stroke, reports a research update in the American Journal of Physical Medicine & Rehabilitation, the official journal of the Association of Academic Physiatrists.

10 May 2018

New MRI glove prototype shows promise in future diagnosis of repetitive strain injuries

A new kind of MRI component in the shape of a glove delivers the first clear images of bones, tendons and ligaments moving together, a new study finds.

9 May 2018

Fresh Ebola outbreak in Congo reported

Yesterday (8th May 2018), the Government of the Democratic Republic of the Congo declared a new outbreak of Ebola in the rural northwest of the country. This came after two cases of Ebola were confirmed in regions of Bikoro.

9 May 2018

FDA grants approval for two drugs administered together to treat aggressive form of thyroid cancer

The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).

8 May 2018

FDA authorizes marketing of Hemospray device for treating GI bleeding

Today, the U.S. Food and Drug Administration permitted marketing of Hemospray, a new device used to help control certain types of bleeding in the gastrointestinal (GI) tract.

8 May 2018

Powered stapler use linked to reduced rates of bleeding complications in VATS lobectomy patients

Bleeding complications dropped by nearly half when surgeons used a powered stapler as opposed to a manual device in what researchers say is the first real-world assessment of the two technologies in video-assisted thoracoscopic surgery for lung cancer.

4 May 2018